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Uncomplicated moderate coronary artery
dissections after balloon angioplasty: good
outcome without stenting
M Albertal, G Van Langenhove, E Regar, I P Kay, D Foley, G Sianos, K Kozuma,
T Beijsterveldt, S G Carlier, J A Belardi, E Boersma, J E Sousa, B de Bruyne, P W Serruys,
on behalf of the DEBATE II Study Group
Abstract
Objective—To study the relation between moderate coronary dissections, coronary flow velocity
reserve (CFVR), and long term outcome.
Methods—523 patients undergoing balloon angioplasty and sequential intracoronary Doppler
measurements were examined as part of the DEBATE II trial (Doppler endpoints balloon angio-
plasty trial Europe). After successful balloon angioplasty, patients were randomised to stenting or
no further treatment. Dissections were graded at the core laboratory by two observers and
divided into four categories: none, mild (type A-B), moderate (type C), severe (types D to F).
Patients with severe dissections (n = 128) or without available reference vessel CFVR (n = 139)
were excluded. The remaining 256 patients were divided into two groups according to the pres-
ence (group A, n = 45) or absence (group B, n = 211) of moderate dissection.
Results—Following balloon angioplasty, there was no diVerence in CFVR between the two
groups. At 12 months follow up, a higher rate of major adverse cardiac events was observed over-
all in group A than in group B (10 (22%) v 23 (11%), p = 0.041). However, the risk of major
adverse events was similar in the subgroups receiving balloon angioplasty (group A, 6 (19%) v
group B, 16 (16%), NS). Among group A patients, the adverse events risk was greater in those
randomised to stenting (odds ratios 6.603 v 1.197, p = 0.046), whereas there was no diVerence
in risk if the group was analysed according to whether the CFVR was < 2.5 or> 2.5 after balloon
angioplasty.
Conclusions—Moderate dissections left untreated result in no increased risk of major adverse
cardiac events. Additional stenting does not improve the long term outcome.
(Heart 2001;86:193–198)
Keywords: coronary dissection; intracoronary Doppler; angioplasty
Coronary artery dissection is observed angi-
ographically in up to 50% of cases after balloon
angioplasty.1 2 Although coronary stenting has
greatly curbed the need for urgent surgical
revascularisation for dissections that impair
distal perfusion, it remains to be established
whether moderate dissections with unimpaired
flow and a good epicardial lumen would benefit
from additional stenting. Previous studies have
shown that mild to moderate angiographic dis-
sections do not increase the risk of major
adverse cardiac events or restenosis rate at a six
months follow up after balloon angioplasty.3 4
However, limited data are available on the
impact of stenting on the short and long term
clinical outcome after the development of
moderate dissections.
We investigated the relation between dissec-
tion after balloon angioplasty and coronary
flow velocity reserve, and the impact of stenting
on the subsequent clinical outcome in patients
treated by balloon angioplasty or stenting in
the DEBATE II trial (Doppler endpoints
balloon angioplasty trial Europe).
Methods
PATIENTS
Patients scheduled to undergo angioplasty
because of stable or unstable angina pectoris or
documented myocardial ischaemia, caused by
a single de novo coronary stenosis less than
25 mm long and potentially amenable to stent
implantation, were eligible for the DEBATE II
trial. Those with total coronary occlusions,
ostial lesions, bifurcated lesions, lesions in a
previously bypassed vessel, lesions in an
extremely tortuous vessel, or lesions containing
thrombus were excluded from the study, as
were patients with previous Q wave infarction
in the myocardial territory supplied by the tar-
get vessel, or evolving myocardial infarction in
the previous week. The study was carried out
according to the principles of the Declaration
of Helsinki, and all patients provided written
informed consent.
STUDY OBJECTIVES AND DESIGN
The primary objective of the DEBATE II trial
was to compare the cost-eVectiveness of
elective stent implantation (primary stenting)
with balloon angioplasty guided by quantitative
coronary angiography and Doppler flow veloc-
ity measurements. Stent implantation was per-
mitted for bail out situations or whenever an
“optimal result” could not be achieved. The
secondary objective was to evaluate diVerences
in benefits of additional stenting in patients
with and without an optimal result. Thus a
double randomisation was required. The first
randomisation (1:5) allocated 620 patients to
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either primary stenting (n = 97) or guided bal-
loon angioplasty (n = 523). All patients in the
guided balloon angioplasty group who did not
require bail out stenting (n = 395) underwent a
second randomisation to additional stenting or
termination of the procedure. For the purpose
of our analysis, we selected from the latter 395
patients all those (n = 256) in whom a
reference vessel coronary flow velocity reserve
(CFVR) measurement was available, and
divided them according to the presence or
absence of moderate type C dissections (fig 1).
GUIDED BALLOON ANGIOPLASTY
Doppler flow measurements
Target vessel Doppler measurements were per-
formed before and after balloon angioplasty
and again following additional stent implanta-
tion. It was also a requirement to perform a
Doppler assessment of the CFVR of an
adjacent angiographically non-diseased refer-
ence vessel (< 30% diameter stenosis). A 0.014
inch (0.36 mm) Doppler guide wire (Cardio-
metrics FloWire; EndoSonics, Rancho Cor-
dova, California, USA) was advanced distal to
the lesion, and velocity recordings were ob-
tained under basal and hyperaemic conditions.
Maximum hyperaemia was induced by adeno-
sine, either by an intracoronary bolus injection
(12 µg for the right coronary artery and 18 µg
for the left coronary artery) or by intravenous
infusion (140 µg/kg/min). Absolute CFVR was
calculated as the ratio of hyperaemic to
baseline time averaged peak velocity. Relative
CFVR was calculated as the ratio of the abso-
lute CFVR to the non-diseased reference vessel
CFVR.
Quantitative coronary angiography
Intracoronary glyceryl trinitrate 0.1–0.3 mg or
isosorbide dinitrate 1–3 mg was given to
achieve maximum coronary vasodilatation. At
least two cineangiograms were performed
before the angioplasty or stenting procedure
and were repeated in the same projections
afterwards. Quantitative angiography was per-
formed using a standardised protocol de-
scribed previously.5 6
Definition of an “optimal” result
An “optimal” result (on quantitative angio-
graphy and coronary flow reserve determina-
tion) was defined as a diameter stenosis of
< 35% and a coronary flow reserve of > 2.5,7
and was achieved by upsizing the balloon or
increasing the inflation pressure, or both, if
necessary.
BAIL OUT STENTING
Bail out stenting was allowed in the following
situations: a residual stenosis of more than
50%; dissection of type D, E, or F; persistent
myocardial ischaemia along with a dissection
type C; a fall in thrombolysis in myocardial inf-
arction (TIMI) flow grade of at least one grade;
or TIMI grade 0 or 1.
SECOND RANDOMISATION
After an optimal result was achieved or when
further attempts to improve the result were
deemed unsafe by the operator, the final diam-
eter stenosis and coronary flow velocity reserve
were assessed. Thereafter, and irrespective of
these measurements, the second randomisa-
tion was performed.
DISSECTION EVALUATION
Intimal dissection incidence and grading was
determined by an independent core laboratory
(Cardialysis BV) classification,1 blinded to
Doppler flow results and clinical outcome,
according to the National Heart, Lung, and
Blood Institute (NHLBI) classification:
x type A: small radiolucent area within the
vessel;
x type B: no persisting extravasations of
contrast;
x type C: persisting contrast medium extrava-
sations;
x type D: spiral filling defect with delayed but
complete distal flow;
x type E: persistent filling defect with delayed
antegrade flow;
x type F: filling defect with total occlusion.
Dissections were clinically divided into
“mild” dissections (type A or B), “moderate”
dissections (type C without signs or symptoms
of ischaemia), or “severe” dissections (type C
with symptoms or signs of ischaemia plus types
D to F). The patient population was analysed
on the basis of the presence (group A) or
absence (group B) of uncomplicated moderate
dissections.
Figure 1 Study population. All patients allocated to the guided balloon angioplasty group
of the DEBATE II trial who did not require bail out stenting formed the population for our
substudy (395 patients). Of these, 139 had no data of the reference vessel coronary flow
velocity reserve available and were therefore excluded from further analysis. The remaining
256 patients underwent a second randomisation to additional stenting or termination of the
procedure.We analysed these patients depending on the presence (group A) or absence
(group B) of uncomplicated “moderate” dissections.
Guided balloon
angioplasty
n = 523
Bail-out stenting
n = 128
Patients without
ref CFVR
n = 139
Non-type C
n = 211
Type C
n = 45
Stent
group
n = 111
Balloon
group
n = 100
Stent
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Balloon
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Moderate dissection groups Non-moderate dissection groups
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EFFICACY END POINTS
For the DEBATE II study, the eYcacy end
point was a composite of major adverse cardiac
events within 12 months after the procedure
and included the following: death from any
cause, non-fatal myocardial infarction, and
percutaneous or surgical target lesion revascu-
larisation. After hospital discharge, patients
were seen at the outpatient clinic at one, six,
and 12 months. No follow up angiogram was
performed unless clinically indicated.
STATISTICAL ANALYSIS
Continuous variables are expressed as mean
(SD), and diVerences between groups of
patients were studied using the unpaired
Student’s t test or one way analysis of variance,
as appropriate. Categorical variables are pre-
sented as percentages, and diVerences between
groups were evaluated using the ÷2 test or Fish-
er’s exact test. Multivariate logistic regression
analysis was used to study the value of the
clinical, angiographic, and Doppler derived
data to predict major adverse cardiac events at
the 12 months follow up. Odds ratios and 95%
confidence intervals (CI) are presented. The
Breslow-Day test was used to assess the homo-
geneity of odds ratios between subgroups. The
log rank test was applied to study diVerences in
event-free survival between subgroups at the
12 months follow up. All statistical tests were
two tailed, and significance was assumed at
p < 0.05.
Results
From 523 patients randomised to the guided
angioplasty group in the DEBATE II trial, 128
underwent bail out stenting because of severe
dissections. All the remaining patients
(n = 395), irrespective of the presence or
absence of a moderate dissection, underwent a
second randomisation to additional stenting or
to halting the procedure. Of these 395 patients,
139 were excluded from our analysis because
no reference CFVR measurements were avail-
able. The remaining 256 patients were divided
into two groups according the presence (group
A, n = 45) or absence (group B, n = 211) of
uncomplicated moderate dissections (fig 1).
BASELINE CHARACTERISTICS
Patients’ baseline characteristics are summa-
rised in table 1. Patients in group A were older
and had a smaller proportion of smokers than
those in group B.
Lesion characteristics are given in table 2.
Group A had a greater proportion of calcified
lesions than group B. Both groups had similar
vessel size (mean (SD): 2.93 (0.43) mm v 3.03
(0.59) mm, group A v group B, respectively
(NS)). In group B, 110 of the 211 patients
(53%) had no dissection, whereas 101 (47%)
showed “mild” dissections.
Stent length was similar in both groups
(16.3 mm v 15.6 mm in groups A and B,
respectively; p = 0.64).
CORONARY DISSECTION SEVERITY AND CORONARY
FLOW
For both groups, baseline and hyperaemic
averaged peak velocity values before and after
the procedure are given in fig 2. The preinter-
ventional hyperaemic response was slightly
impaired in the group A patients randomised to
stenting. After balloon angioplasty, both
groups showed similar baseline and hyperae-
mic averaged peak velocity values. In patients
randomised to additional stent implantation,
no diVerences in baseline and hyperaemic
averaged peak velocities were seen.
Absolute and relative CFVR values are given
in table 3. Before and after balloon angioplasty,
absolute CFVR was similar in the patient
population as a whole. However, in the
subgroup randomised to stenting, the absolute
CFVR was lower in group A than in group B.
As the non-diseased reference vessel CFVR
was also significantly lower in group A than in
group B (2.43 (0.71) v 2.91 (0.78), p < 0.001),
the resulting relative CFVR after stent implan-
tation was similar in the two groups.
CORONARY DISSECTION SEVERITY AND CLINICAL
OUTCOME
Complete follow up data were obtained in all
patients. Thirty three cardiac events occurred.
There were five deaths (one in group A and
four in group B) and six myocardial infarcts
Table 1 Baseline characteristics of the patients according to dissection score following
balloon angioplasty
Characteristic
Dissection
p Value
Type C (group A)
(n=45)
None/type A-B (group B)
(n=211)
Age (years) (mean (SD)) 62 (11) 57 (11) 0.011
Female sex 33 (73%) 157 (74%) NS
Diabetes mellitus 3 (7%) 23 (11%) NS
Family history 21 (47%) 73 (35%) NS
Hypertension 14 (31%) 86 (41%) NS
Hypercholesterolaemia 21 (47%) 117 (55%) NS
Smoking 23 (51%) 145 (69%) 0.014
CCS functional class NS
I 3 (9%) 8 (7%)
II 19 (56%) 61 (50%)
III 11 (32%) 46 (38%)
IV 1 (3%) 6 (5%)
Unstable angina* 11 (32%) 89 (42%) NS
Values are n (%) unless stated.
CCS, Canadian Cardiovascular Society; type C, moderate dissection; type A-B, very minor
dissection.
*Patients with unstable angina were excluded from the analysis of the CCS functional class.
Table 2 Lesion characteristics in the two subgroups
Characteristic
Dissection
p Value
Type C (group A)
(n=45)
None/type A-B
(group B) (n=211)
Eccentricity Yes 31 (69%) 125 (60%)
NSNo 15 (31%) 85 (40%)
Length < 10 mm 23 (51%) 95 (49%)
NS> 10 mm 22 (49%) 92 (47%)
Accessibility No tortuosity 43 (93%) 180 (86%)
NS
Moderate
tortuosity
3 (6%)
28 (13%)
Excess tortuosity 0 2 (1)
Angulation* None 41 (89%) 185 (88%)
NS
Moderate 5 (11%) 25 (12%)
Severe bend point 0 0
Calcification Little or none 39 (85%) 198 (94%)
0.026Moderate to heavy 7 (15%) 12 (6%)
Values are mean (%).
*None, < 45°; moderate, > 45° to 90°; severe, > 90°.
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(one in group A and five in group B). At 12
months, the rate of target lesion revascularisa-
tion and major adverse cardiac events was
higher in group A than in group B (table 4).
Event-free survival at 12 months was 78% in
group A v 89% in group B (p = 0.041).
All variables for which univariate analysis
yielded a significant diVerence (age, smoking,
degree of lesion calcification) were entered into
the multivariate logistic model as potential
predictors of major adverse cardiac events,
along with the presence of moderate dissec-
tions. The presence of moderate dissections
was the only independent predictor of major
adverse cardiac events (odds ratio 2.42; 95%
CI, 1.06 to 5.57; p = 0.036).
IMPACT OF STENTING ON MODERATE
DISSECTIONS
Among group A patients, those randomised to
stent implantation had a higher rate of major
adverse cardiac events than those randomised
to stopping the procedure (31% v 19%). The
Breslow-Day test for homogeneity of odds
ratios between the two patient subgroups was
significant, showing a higher risk of major
adverse cardiac events at 12 months of follow
up in the stent arm (odds ratios 6.603 v 1.197,
p = 0.046). The CFVR (< 2.5 v > 2.5) before
second randomisation did not aVect the long
term outcome (odds ratios 3.617 v 1.410,
p = 0.287).
Discussion
The main findings of our study are that
uncomplicated moderate dissections after bal-
loon angioplasty left untreated had a good long
term clinical outcome. In agreement with these
results, several angioplasty studies have
described a lack of association between the
Figure 2 Baseline (b-APV) and hyperaemic (h-APV) average peak velocities before and after the procedure in group A
and group B.Upper panels show the subgroup randomised to stopping the procedure after balloon angioplasty (BA); lower
panels show the subgroup randomised to further stent implantation (stent).
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Table 3 Coronary flow velocity data
Group A Group B
Stent group
(n=13)
Balloon group
(n=32)
Stent group
(n=111)
Balloon group
(n=100)
DS before BA (%) 76 (7) 69 (11) 68 (10)† 68 (11)
DS after BA (%) 23 (8) 23 (7) 22 (10) 21 (8)
DS after stenting (%) 7 (9) – 8 (8) –
CFVR before BA 1.29 (0.32)* 1.55 (0.52) 1.64 (0.61) 1.64 (0.60)
CFVR after BA 2.04 (0.59)* 2.65 (0.95) 2.50 (0.74) 2.50 (0.73)
CFVR after stenting 2.33 (0.87) – 2.88 (0.30)† –
RCFVR before BA 0.57 (0.21) 0.57 (0.19) 0.60 (0.25) 0.58 (0.21)
RCFVR after BA 0.86 (0.17) 1.00 (0.28) 0.89 (0.27) 0.89 (0.27)†
RCFVR after stenting 0.97 (0.24) – 1.02 (0.30) –
Reference CFVR 2.43 (0.71)* 2.83 (0.81) 2.91 (0.78)† 2.90 (0.75)
Values are mean (SD).
*p < 0.05 v balloon group A; †p < 0.05 v same subgroup in group A.
BA, balloon angioplasty; CFVR, coronary flow velocity reserve; DS, percentage diameter stenosis;
group A, patients with moderate dissections; group B, patients with no or minimal dissection;
RCFVR, relative CFVR.
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presence of a moderate dissection and the long
term clinical outcome.8–10 Previous three di-
mensional intracoronary ultrasound data from
our group have shown that the presence of inti-
mal dissection is associated with a greater total
vessel volume at long term follow up, probably
owing to favourable remodelling.11 It is con-
ceivable that the development of a more deeply
seated injury reduces vessel wall strength,
thereby predisposing to favourable remodel-
ling.
Overall, the patients with moderate dissec-
tions had a worse outcome than those with no
or minimal dissections. This probably reflects
the findings in the stented subgroup, which had
a higher risk of major adverse cardiac events
than the group with moderate dissections but
without additional stenting. Although stents
were placed according to the DEBATE II pro-
tocol and not to the operator’s preference, the
small sample size (n = 13) prevents us from
drawing any firm conclusions. While coronary
stenting after the development of moderate
dissections has proved to reduce the acute
complication rate, there is no established long
term clinical benefit of additional stenting in
patients with uncomplicated moderate dissec-
tion (TIMI 3 flow and absence of signs or
symptoms of angina). Recent reports have
shown that coronary stent implantation causes
more severe injury and a greater inflammatory
response, as well as worse endothelial dysfunc-
tion, than plain balloon angioplasty.12–15 It is
conceivable that the combination of a deep
arterial injury associated with a moderate
dissection and the implantation of a metallic
body may cause a synergistic proliferative
response.16 In patients with moderate dissec-
tions, preventing favourable remodelling might
oVset the beneficial stent scaVolding eVect.
The latter could be particularly important as
these patients are expected to develop an
enhanced neointimal response.16 17
Our group has previously reported a tempo-
rary reduction in absolute coronary flow
reserve in patients who developed uncompli-
cated moderate dissections.18 This reflected a
transient increase in the baseline velocity.
Therefore the reduced coronary flow reserve
values did not translate into a greater residual
stenosis and obstruction of coronary blood
flow. In the present study, we used the relative
CFVR—a more reliable index of persistent
conduit obstruction than the absolute
CFVR19—and found similar values between the
two groups. The latter results indicate that
without signs or symptoms of ischaemia and
the presence of TIMI 3 flow, no significant
obstruction to coronary blood flow should be
expected in patients experiencing mild to
moderate dissections.
Although the use of long or multiple stents
has recently been reported to be associated
with a greater restenosis risk,20–22 in our study
similar lengths and numbers of stents per
patient were used in the two groups, so this is
unlikely to be a confounding factor.
LIMITATIONS
The limited number of patients with moderate
dissections prevents us from drawing definitive
conclusions. However, this is the largest
prospective study investigating a selected
population of patients who developed uncom-
plicated moderate dissections and underwent
randomisation to additional stenting or no fur-
ther treatment, and in whom post-procedural
Doppler flow data and one year follow up data
were available.
CONCLUSIONS
Moderate dissections left unstented do not
have an adverse clinical outcome. Additional
stenting does not appear to be of benefit.
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IMAGES IN CARDIOLOGY
Obliteration of a coronary artery aneurysm with a
covered coronary stent
A 71 year old man with a history of limiting
stable exertional angina who had required
admission for unstable angina on two occa-
sions in the preceding year underwent elective
coronary angiography. Risk factors included
hypertension, non-insulin dependent diabetes,
hypercholesterolaemia, and previous smoking.
Angiography showed single vessel disease of
the left anterior descending artery (LAD) (top:
right anterior oblique 30° caudal 10°). Just dis-
tal to the first diagonal there was a discrete
coronary aneurysm with a severe stenosis
proximally. After pre-inflation with a 2.5 mm
balloon a 16 × 3.5 mm JoMed Jostent coronary
stent graft was deployed at 18 atm, achieving
excellent flow in the LAD and aneurysm oblit-
eration (bottom: right anterior oblique 45°
caudal 10°). The patient was discharged on a
one month course of clopidogrel and remains
asymptomatic at follow up.
The Jostent coronary stent graft is a
polytetrafluoethylene (PTFE) stent sandwich
ideally suited for treatment of coronary aneu-
rysms, perforations, and fistulae.
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